Related Experiment Video
Updated: May 15, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Simplified regional citrate anticoagulation using a calcium-containing replacement solution for continuous venovenous
Ling Zhang1, Yujie Liao, Jin Xiang
1West China Hospital of Sichuan University, Chengdu, Sichuan, China. zhanglinglzy@163.com
Summary
This study introduces a simplified regional citrate anticoagulation (RCA) protocol for continuous venovenous hemofiltration (CVVH) using a standard calcium-containing replacement solution. The simplified RCA method proved safe and effective, eliminating the need for separate calcium infusions.
Area of Science:
- Nephrology
- Critical Care Medicine
- Biomedical Engineering
Background:
- Regional citrate anticoagulation (RCA) is often underutilized due to its complexity, requiring specialized solutions and continuous calcium infusion.
- Existing RCA protocols necessitate specialized calcium-free replacement solutions and dedicated intravenous calcium administration, increasing procedural complexity.
- The need for a simplified and safer RCA protocol for continuous venovenous hemofiltration (CVVH) is critical for broader clinical adoption.
Purpose of the Study:
- To design and evaluate a simplified regional citrate anticoagulation (RCA) protocol for continuous venovenous hemofiltration (CVVH).
- To assess the efficacy and safety of using a standard calcium-containing replacement solution with RCA in CVVH.
- To determine if the simplified RCA protocol can obviate the need for continuous intravenous calcium infusion.
Main Methods:
- A simplified RCA protocol was developed using a commercial calcium-containing replacement solution for CVVH.
- Thirty-six patients underwent RCA-based pre-dilution CVVH with a target post-filter ionized calcium level of 0.25–0.5 mmol/L.
- Citrate and ionized calcium levels were monitored, alongside hemofilter survival and patient safety parameters (bleeding, hypocalcemia, citrate toxicity).
Main Results:
- The simplified RCA protocol demonstrated effective anticoagulation, with mean hemofilter survival of 61.3 hours.
- Hemofilter patency rates were 92% at 24h, 63% at 48h, and 48% at 72h.
- No bleeding episodes, hypocalcemia, or citrate toxicity were observed in any patient.
Conclusions:
- The simplified regional citrate anticoagulation protocol using a calcium-containing replacement solution is effective and safe for CVVH.
- This simplified approach eliminates the requirement for a separate intravenous calcium infusion catheter.
- The findings support the broader clinical application of RCA in CVVH by reducing procedural complexity.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...